Express report: pharmaceuticals

Ended Awarded

Contract number
VA24617E7311
Awardee
Awarding agency
Obligated
$135,546

Award facts

Contract value 100% obligated
$135,546.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20910, USA

Award details come from SAM.gov/FPDS.

About this award

This $135,546 firm fixed price delivery order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to United Therapeutics Corp, a biotechnology company focused on developing treatments for pulmonary arterial hypertension and other life-threatening diseases. The order was placed against United Therapeutics' pre-competed Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs, and did not utilize any set-asides. The contract called for United Therapeutics to provide Tyvaso inhalation solution and starter/refill kits, as well as the related drugs Remodulin, Orenitram, and Unituxin, to support VA distribution of pulmonary arterial hypertension and cancer treatments to veterans nationwide. United Therapeutics holds two national Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with the VA, including a $50 million Blanket Purchase Agreement and a $198 million task order on the Pharmaceuticals and Drugs schedule, which help streamline VA's procurement of United Therapeutics' specialty pharmaceutical portfolio.

Quick answers

Who was awarded contract VA24617E7311?

VA24617E7311 was awarded to United Therapeutics Corp by Veterans Integrated Service Network 6 (Veterans Health Administration) on July 6, 2017.

How much is contract VA24617E7311 worth?

The government has obligated $135,546 on VA24617E7311.

Is contract VA24617E7311 an order under another contract?

Yes. VA24617E7311 is a BPA call under V797D40275-VA797P15A0007, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract VA24617E7311 competed?

The extent of competition for VA24617E7311 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award